What medications are used to treat onychomycosis (nail fungus) of the hands?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Fingernail Onychomycosis (Hand Nail Fungus)

For fingernail onychomycosis, oral terbinafine 250 mg once daily for 6 weeks is the first-line treatment, with itraconazole pulse therapy (400 mg daily for 1 week per month for 2 months) as the preferred alternative if terbinafine cannot be used. 1, 2

First-Line Systemic Treatment: Terbinafine

Terbinafine is the gold standard for dermatophyte fingernail infections due to its superior fungicidal activity, higher cure rates, and minimal drug interactions compared to azole antifungals. 1, 2

Dosing and Duration

  • 250 mg once daily for 6 weeks for fingernail infections 1, 3
  • Can be taken with or without food 2
  • The drug persists in nails for 6 months after treatment completion, allowing continued antifungal activity 2

Pre-Treatment Requirements

  • Obtain baseline liver function tests (LFTs) and complete blood count (CBC) before initiating therapy 1, 2
  • Confirm diagnosis with laboratory testing (KOH preparation, fungal culture, or nail biopsy) 3

Monitoring During Treatment

  • Monitor LFTs if patient has history of hepatitis, heavy alcohol use, or is on concomitant hepatotoxic medications 1, 2
  • Re-evaluate patient 3-6 months after treatment initiation to assess response 2, 4

Contraindications

  • Active or chronic liver disease (absolute contraindication) 1, 2
  • Lupus erythematosus (absolute contraindication) 2
  • History of allergic reaction to oral terbinafine 3

Common Adverse Effects

  • Headache, taste disturbance, and gastrointestinal upset 1
  • Can aggravate psoriasis and cause subacute lupus-like syndrome 1
  • Rare but serious: Stevens-Johnson syndrome and toxic epidermal necrolysis 2

Second-Line Systemic Treatment: Itraconazole

If terbinafine is contraindicated or not tolerated, itraconazole pulse therapy is the preferred alternative. 1

Dosing Options

  • Pulse therapy (preferred): 400 mg daily (200 mg twice daily) for 1 week per month for 2 months (2 pulses total for fingernails) 1, 5
  • Continuous therapy: 200 mg daily for 12 weeks 5

Administration Requirements

  • Must be taken with food and acidic beverages for optimal absorption 1, 5
  • Monitor hepatic function tests at baseline and during therapy, especially with concomitant hepatotoxic drug use 1, 5

Contraindications and Cautions

  • Heart failure (contraindicated due to negative inotropic effects) 5
  • Hepatotoxicity or active liver disease 5
  • Significant drug interactions with statins - use caution and monitor closely 5

Third-Line Systemic Treatment: Fluconazole

Fluconazole is reserved for patients who cannot tolerate both terbinafine and itraconazole. 1

Dosing

  • 150-450 mg once weekly for 3 months for fingernail infections 1
  • Baseline LFTs and CBC required 1
  • Monitor LFTs during high-dose or prolonged therapy 1

Topical Therapy Options

Topical antifungals can be used as adjunctive therapy to systemic treatment or as monotherapy for mild, superficial infections. 1

Available Topical Agents

  • Amorolfine 5% lacquer: Apply once or twice weekly for 6-12 months 1
  • Ciclopirox 8% lacquer: Apply once daily for up to 48 weeks 1
  • Efinaconazole 10% solution: Shows mycological cure rates approaching 50% after 48 weeks 5, 6
  • Tioconazole 28% solution: Apply twice daily for 6-12 months 1

When to Consider Topical Therapy

  • Mild disease with limited nail involvement 6
  • Superficial and distal onychomycosis 1
  • Patients in whom systemic therapy is contraindicated 1
  • Combination with systemic therapy enhances cure rates through antimicrobial synergy 5

Treatment Algorithm

  1. Confirm diagnosis with laboratory testing (KOH, culture, or biopsy) before initiating treatment 3
  2. Assess severity: Determine extent of nail involvement and presence of matrix involvement
  3. Check for contraindications: Review liver function, cardiac history, and current medications
  4. First choice: Terbinafine 250 mg daily for 6 weeks 1, 2
  5. If terbinafine contraindicated: Itraconazole pulse therapy (400 mg daily for 1 week/month × 2 months) 1
  6. If both contraindicated: Fluconazole 150-450 mg weekly for 3 months 1
  7. Consider adding topical therapy for enhanced efficacy 5

Important Clinical Pearls

  • Fingernail infections respond much better than toenail infections to shorter treatment durations 7
  • Clinical improvement lags behind mycological cure - healthy nail growth takes months after treatment completion 3
  • Griseofulvin is not recommended due to lower efficacy (30-40% cure rates), longer treatment duration (6-9 months), and higher relapse rates 1, 5
  • Terbinafine has minimal drug interactions compared to azole antifungals, making it safer for patients on multiple medications 2, 4
  • The main interaction concern with terbinafine is drugs metabolized by cytochrome P450 2D6 (certain antidepressants, beta-blockers, antiarrhythmics) 2

Monitoring Treatment Response

  • Re-evaluate at 3-6 months after starting treatment 2, 4
  • If disease persists, a new treatment course can be started without additional waiting period 2
  • Assessment should include both mycological testing (KOH and culture) and clinical examination 5
  • Monitor for at least 48 weeks from start of treatment to identify potential relapse 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Terbinafine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Terbinafine Treatment for Onychomycosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Severe Onychomycosis and Symptomatic Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Updated Perspectives on the Diagnosis and Management of Onychomycosis.

Clinical, cosmetic and investigational dermatology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.